1. Home
  2. PLSE vs ORKA Comparison

PLSE vs ORKA Comparison

Compare PLSE & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • ORKA
  • Stock Information
  • Founded
  • PLSE 2014
  • ORKA 2004
  • Country
  • PLSE United States
  • ORKA United States
  • Employees
  • PLSE N/A
  • ORKA N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • PLSE Health Care
  • ORKA Health Care
  • Exchange
  • PLSE Nasdaq
  • ORKA Nasdaq
  • Market Cap
  • PLSE 1.1B
  • ORKA 354.2M
  • IPO Year
  • PLSE 2016
  • ORKA N/A
  • Fundamental
  • Price
  • PLSE $14.84
  • ORKA $11.80
  • Analyst Decision
  • PLSE
  • ORKA Strong Buy
  • Analyst Count
  • PLSE 0
  • ORKA 8
  • Target Price
  • PLSE N/A
  • ORKA $39.71
  • AVG Volume (30 Days)
  • PLSE 190.1K
  • ORKA 325.7K
  • Earning Date
  • PLSE 08-11-2025
  • ORKA 08-15-2025
  • Dividend Yield
  • PLSE N/A
  • ORKA N/A
  • EPS Growth
  • PLSE N/A
  • ORKA N/A
  • EPS
  • PLSE N/A
  • ORKA N/A
  • Revenue
  • PLSE N/A
  • ORKA N/A
  • Revenue This Year
  • PLSE N/A
  • ORKA N/A
  • Revenue Next Year
  • PLSE N/A
  • ORKA N/A
  • P/E Ratio
  • PLSE N/A
  • ORKA N/A
  • Revenue Growth
  • PLSE N/A
  • ORKA N/A
  • 52 Week Low
  • PLSE $10.52
  • ORKA $5.49
  • 52 Week High
  • PLSE $25.00
  • ORKA $52.32
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 35.78
  • ORKA N/A
  • Support Level
  • PLSE $14.76
  • ORKA N/A
  • Resistance Level
  • PLSE $15.40
  • ORKA N/A
  • Average True Range (ATR)
  • PLSE 0.70
  • ORKA 0.00
  • MACD
  • PLSE -0.08
  • ORKA 0.00
  • Stochastic Oscillator
  • PLSE 8.33
  • ORKA 0.00

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

Share on Social Networks: